Conversational AI Agents for Psychological Support in Cancer Care—Clinical Safety and Evaluation Gaps
OVERVIEWA scoping review in JMIR examining conversational AI agents designed for psychological support of cancer patients reveals significant gaps in safety evaluation and clinical evidence. The research maps heterogeneous technologies spanning chatbots, voice agents, and specialized psycho-oncology platforms across varying developmental stages. Key Findings: - Clinical and safety evaluation remains incompletely reported across the literature - Theoretical foundations for psychological intervention are often lacking - Population representation in development and testing is narrow - Professional oversight responsibilities and referral protocols are undefined - Most published research represents reporting patterns rather than established effectiveness or safety Implications for Practice: The review emphasizes that future studies must prospectively evaluate both psychosocial benefit and safety before clinical deployment. The field requires clarity on professional oversight—specifically, which clinicians should monitor interactions, when escalation occurs, and how systems handle crisis situations. Current evidence does not establish that these systems improve psychological outcomes in cancer care. Regulatory Gap: Unlike FDA-cleared medical devices, conversational AI for mental health support in oncology operates in a largely unregulated space. The review calls for defining governance structures before widespread adoption. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.